Skip to search formSkip to main contentSkip to account menu

CCT018159

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
AimsThe preservation of pancreatic β-cell function is a key point in the treatment of type 2 diabetes mellitus. There is… 
2015
2015
PurposeCushing’s disease is primarily caused by adrenocorticotropic hormone (ACTH)-producing pituitary adenomas. If excision of… 
2010
2010
Molecular chaperone heat shock protein 90 (Hsp90) inhibitors are promising targeted cancer therapeutic drugs, with the advantage… 
Highly Cited
2007
Highly Cited
2007
Although the heat shock protein 90 (HSP90) inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) shows clinical promise… 
Highly Cited
2007
Highly Cited
2007
The molecular chaperone heat shock protein 90 (HSP90) has emerged as an exciting molecular target. Derivatives of the natural… 
2006
2006
CCT018159 was recently identified as a novel inhibitor of heat shock protein (Hsp) 90, a promising target for cancer therapy… 
2005
2005
High-throughput screening of chemical libraries and the subsequent rapid progress of hit compounds through an iterative…